Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02914405
Title Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma (MiniVan)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Hospital Southampton NHS Foundation Trust
Age Groups: adult | child
Covered Countries USA

No variant requirements are available.